As of Aug 18
| +0.25 / +0.94%|
The 24 analysts offering 12-month price forecasts for Boston Scientific Corp have a median target of 31.00, with a high estimate of 34.00 and a low estimate of 24.00. The median estimate represents a +15.28% increase from the last price of 26.89.
The current consensus among 28 polled investment analysts is to Buy stock in Boston Scientific Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.